These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30740284)

  • 1. Angiotensin II Use in Refractory Multisystem Shock: A Case Report.
    Ahmed M; Habis S; Mahmoud A; Rutland C; Saeed R
    Cureus; 2018 Nov; 10(11):e3665. PubMed ID: 30740284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock.
    Allen JM; Gilbert BW
    Clin Ther; 2019 Dec; 41(12):2594-2610. PubMed ID: 31668356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Review of Angiotensin II Use in Adult Patients With Refractory Distributive Shock.
    Wong A; Alkazemi A; Eche IM; Petri CR; Sarge T; Cocchi MN
    J Intensive Care Med; 2020 Dec; 35(12):1490-1496. PubMed ID: 31480886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Angiotensin II for Catecholamine Refractory Septic or Distributive Shock on Mortality: A Propensity Score Weighted Analysis of Real-World Experience in the Medical ICU.
    Quan M; Cho N; Bushell T; Mak J; Nguyen N; Litwak J; Rockwood N; Nguyen HB
    Crit Care Explor; 2022 Jan; 4(1):e0623. PubMed ID: 35072084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressor-Refractory Shock From Clozapine Overdose Treated With Synthetic Angiotensin II Infusion.
    Wieruszewski PM; Nelson S; Wittwer ED; Leung JG
    Crit Care Explor; 2020 Sep; 2(9):e0185. PubMed ID: 32984826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II in septic shock.
    Jadhav AP; Sadaka FG
    Am J Emerg Med; 2019 Jun; 37(6):1169-1174. PubMed ID: 30935784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin Associated Lactic Acidosis in the Intensive Care Unit: A Rare Condition Mimicking Sepsis.
    Sendil S; Yarlagadda K; Lawal H; Nookala V; Shingala H
    Cureus; 2020 Jul; 12(7):e9119. PubMed ID: 32699722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Field Expedient Vasopressors During Aeromedical Evacuation: A Case Series from the Puerto Rico Disaster Response.
    Hardwick JM; Murnan SD; Morrison-Ponce DP; Devlin JJ
    Prehosp Disaster Med; 2018 Dec; 33(6):668-672. PubMed ID: 30409234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intubation alone does not mandate trauma surgeon presence on patient arrival to the emergency department.
    Ciesla DJ; Moore EE; Moore JB; Johnson JL; Cothren CC; Burch JM
    J Trauma; 2004 May; 56(5):937-41; discussion 941-2. PubMed ID: 15179230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the Reverse Shock Index at the Injury Scene and in the Emergency Department to Identify High-Risk Patients: A Cross-Sectional Retrospective Study.
    Lai WH; Rau CS; Hsu SY; Wu SC; Kuo PJ; Hsieh HY; Chen YC; Hsieh CH
    Int J Environ Res Public Health; 2016 Mar; 13(4):357. PubMed ID: 27023577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of angiotensin II in treatment of refractory distributive shock.
    Rodriguez R; Fernandez EM
    Am J Health Syst Pharm; 2019 Jan; 76(2):101-107. PubMed ID: 31361800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Effective is Angiotensin II in Decreasing Mortality of Vasodilatory Shock? A Systematic Review.
    Semedi BP; Rehatta NM; Soetjipto S; Nugraha J; Mahyuddin MH; Arnindita JN; Wairooy NAP
    Open Access Emerg Med; 2023; 15():1-11. PubMed ID: 36636460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fresh frozen plasma should be given earlier to patients requiring massive transfusion.
    Gonzalez EA; Moore FA; Holcomb JB; Miller CC; Kozar RA; Todd SR; Cocanour CS; Balldin BC; McKinley BA
    J Trauma; 2007 Jan; 62(1):112-9. PubMed ID: 17215741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Refractory Vasodilatory Shock.
    Jentzer JC; Vallabhajosyula S; Khanna AK; Chawla LS; Busse LW; Kashani KB
    Chest; 2018 Aug; 154(2):416-426. PubMed ID: 29329694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Human Angiotensin II in Pediatric Patients With Vasodilatory Shock: A Report on Two Patients.
    Bailey DM; Chima RS; Tidmarsh GF; Williams MD
    Crit Care Explor; 2019 Aug; 1(8):e0036. PubMed ID: 32166277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad spectrum vasopressors: a new approach to the initial management of septic shock?
    Chawla LS; Ostermann M; Forni L; Tidmarsh GF
    Crit Care; 2019 Apr; 23(1):124. PubMed ID: 30992045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II for Near Drowning: A Case Series.
    Smith SE; Butler SA; Martin J; Gerard D; Sikora Newsome A
    Crit Care Explor; 2021 May; 3(5):e0434. PubMed ID: 34046635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and Outcomes of Patients with Hematological Malignancies Admitted for Intensive Care - a Single Centre Experience.
    Maqsood S; Badar F; Hameed A
    Asian Pac J Cancer Prev; 2017 Jul; 18(7):1833-1837. PubMed ID: 28749114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.